AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
DIMINISHED HIV-1 SENSITIVITY TO STAVUDINE IN PATIENTS ON PROLONGED THERAPY OCCURS ONLY AT LOW-LEVELS AND CANNOT BE ATTRIBUTED TO ANY SINGLEAMINO-ACID SUBSTITUTION IN REVERSE-TRANSCRIPTASE
Authors: SALOMON H MONTANER JSG BELMONTE A WAINBERG MA
Citation: H. Salomon et al., DIMINISHED HIV-1 SENSITIVITY TO STAVUDINE IN PATIENTS ON PROLONGED THERAPY OCCURS ONLY AT LOW-LEVELS AND CANNOT BE ATTRIBUTED TO ANY SINGLEAMINO-ACID SUBSTITUTION IN REVERSE-TRANSCRIPTASE, Antiviral therapy, 3(3), 1998, pp. 177-182
FIRST REPORT OF HIV-2 INFECTION IN ARGENTINA
Authors: LIBONATI O AVILA M ZLATKES R PAMPURO S PERALTA LM RUD E WAINBERG M SALOMON H
Citation: O. Libonati et al., FIRST REPORT OF HIV-2 INFECTION IN ARGENTINA, Journal of acquired immune deficiency syndromes and human retrovirology, 18(2), 1998, pp. 190-191
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ACTIVITY OF ACHYROCLINE FLACCIDA WEIN DC AND GAMOCHAETA-SIMPLICICAULIS AQUEOUS EXTRACTS
Authors: SALOMON H PAMPURO S CAVALLARO L GARCIA G COUSSIO J CAMPOS R
Citation: H. Salomon et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ACTIVITY OF ACHYROCLINE FLACCIDA WEIN DC AND GAMOCHAETA-SIMPLICICAULIS AQUEOUS EXTRACTS, PTR. Phytotherapy research, 11(1), 1997, pp. 82-83
RESISTANCE PROFILE OF A NOVEL 2',3'-DIDEOXYNUCLEOSIDE ANALOG WITH ACTIVITY AGAINST HIV-1
Authors: RICHARD N BELMONTE AR SALOMON H NAGAI K MANSOUR T WAINBERG MA
Citation: N. Richard et al., RESISTANCE PROFILE OF A NOVEL 2',3'-DIDEOXYNUCLEOSIDE ANALOG WITH ACTIVITY AGAINST HIV-1, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1235-1240
CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION
Authors: ANAZODO MI DUTA E SALOMON H FRIESEN AD WAINBERG MA WRIGHT JA
Citation: Mi. Anazodo et al., CHARACTERIZATION OF GPI2A, A POTENT INHIBITOR OF HIV-1 GENE-EXPRESSION AND VIRAL REPLICATION, Nucleosides & nucleotides, 16(7-9), 1997, pp. 1241-1249
MUTATIONS AT CODON-184 IN SIMIAN IMMUNODEFICIENCY VIRUS REVERSE-TRANSCRIPTASE CONFER RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE
Authors: CHERRY E SLATER M SALOMON H RUD E WAINBERG MA
Citation: E. Cherry et al., MUTATIONS AT CODON-184 IN SIMIAN IMMUNODEFICIENCY VIRUS REVERSE-TRANSCRIPTASE CONFER RESISTANCE TO THE (-) ENANTIOMER OF 2',3'-DIDEOXY-3'-THIACYTIDINE, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2763-2765
IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS
Authors: RABOUD JM MONTANER JSG THORNE A SINGER J SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C FANNING M CAMERON W LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SALOMON H SPIRA B CONWAY B AUCLAIR C CASSOL S OSHAUGHNESSY MV WAINBERG MA
Citation: Jm. Raboud et al., IMPACT OF MISSING DATA DUE TO DROPOUTS ON ESTIMATES OF THE TREATMENT EFFECT IN A RANDOMIZED TRIAL OF ANTIRETROVIRAL THERAPY FOR HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 46-55
THE NUCLEOSIDE ANALOG-RESISTANT E89G MUTANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE DISPLAYS A BROADER CROSS-RESISTANCE THAT EXTENDS TO NONNUCLEOSIDE INHIBITORS
Authors: KEW Y SALOMON H OLSEN LR WAINBERG MA PRASAD VR
Citation: Y. Kew et al., THE NUCLEOSIDE ANALOG-RESISTANT E89G MUTANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE DISPLAYS A BROADER CROSS-RESISTANCE THAT EXTENDS TO NONNUCLEOSIDE INHIBITORS, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1711-1714
ENHANCED FIDELITY OF 3TC-SELECTED MUTANT HIV-1 REVERSE-TRANSCRIPTASE
Authors: WAINBERG MA DROSOPOULOS WC SALOMON H HSU M BORKOW G PARNIAK MA GU ZX SONG QB MANNE J ISLAM S CASTRIOTA G PRASAD VR
Citation: Ma. Wainberg et al., ENHANCED FIDELITY OF 3TC-SELECTED MUTANT HIV-1 REVERSE-TRANSCRIPTASE, Science, 271(5253), 1996, pp. 1282-1285
HOST-CELL DEPENDENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE PROFILES AND TISSUE-CULTURE SELECTION PATTERNS
Authors: SALOMON H GU Z GAO Q NAGAI K HISCOTT J WAINBERG MA
Citation: H. Salomon et al., HOST-CELL DEPENDENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DRUG-RESISTANCE PROFILES AND TISSUE-CULTURE SELECTION PATTERNS, Antiviral chemistry & chemotherapy, 6(4), 1995, pp. 222-229
A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/
Authors: PIALOUX G EXCLER JL RIVIERE Y GONZALEZCANALI G FEUILLIE V COULAUD P GLUCKMAN JC MATTHEWS TJ MEIGNIER B KIENY MP GONNET P DIAZ I MERIC C PAOLETTI E TARTAGLIA J SALOMON H PLOTKIN S
Citation: G. Pialoux et al., A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/, AIDS research and human retroviruses, 11(3), 1995, pp. 373-381
SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS
Authors: SALMONCERON D EXCLER JL SICARD D BLANCHE P FINKIELSTZJEN L GLUCKMAN JC AUTRAN B MATTHEWS TJ MEIGNIER B KIENY MP VALENTIN C GONNET P DIAZ I SALOMON H PIALOUX G GONZALEZCANALI G PLOTKIN S
Citation: D. Salmonceron et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS, AIDS research and human retroviruses, 11(12), 1995, pp. 1479-1486
MOLECULAR-BASIS AND CLINICAL-SIGNIFICANCE OF HIV-1 RESISTANCE TO NUCLEOSIDE COMPOUNDS
Authors: WAINBERG MA GU ZX SALOMON H ARTS EJ KLEIMAN L PARNIAK MA MORIN N
Citation: Ma. Wainberg et al., MOLECULAR-BASIS AND CLINICAL-SIGNIFICANCE OF HIV-1 RESISTANCE TO NUCLEOSIDE COMPOUNDS, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 318(3), 1995, pp. 315-328
STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG A NEW CLASS OF ANTIVIRAL HETEROSUBSTITUTED 2',3'-DIDEOXYNUCLEOSIDE ANALOGS
Authors: MANSOUR TS JIN H WANG W DIXIT DM EVANS CA TSE HLA BELLEAU B GILLARD JW HOOKER E ASHMAN C CAMMACK N SALOMON H BELMONTE AR WAINBERG MA
Citation: Ts. Mansour et al., STRUCTURE-ACTIVITY-RELATIONSHIPS AMONG A NEW CLASS OF ANTIVIRAL HETEROSUBSTITUTED 2',3'-DIDEOXYNUCLEOSIDE ANALOGS, Nucleosides & nucleotides, 14(3-5), 1995, pp. 627-635
ANTIVIRAL ACTIVITY AND PROTECTION OF CELLS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 USING AN ANTISENSE OLIGODEOXYRIBONUCLEOTIDE PHOSPHOROTHIOATE COMPLEMENTARY TO THE 5'-LTR REGION OF THE VIRAL GENOME
Authors: ANAZODO MI SALOMON H FRIESEN AD WAINBERG MA WRIGHT JA
Citation: Mi. Anazodo et al., ANTIVIRAL ACTIVITY AND PROTECTION OF CELLS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 USING AN ANTISENSE OLIGODEOXYRIBONUCLEOTIDE PHOSPHOROTHIOATE COMPLEMENTARY TO THE 5'-LTR REGION OF THE VIRAL GENOME, Gene, 166(2), 1995, pp. 227-232
DEVELOPMENT OF HIV-1 RESISTANCE TO (-)2'-DEOXY-3'-THIACYTIDINE IN PATIENTS WITH AIDS OR ADVANCED AIDS-RELATED COMPLEX
Authors: WAINBERG MA SALOMON H GU ZX MONTANER JSG COOLEY TP MCCAFFREY R RUEDY J HIRST HM CAMMACK N CAMERON J NICHOLSON W
Citation: Ma. Wainberg et al., DEVELOPMENT OF HIV-1 RESISTANCE TO (-)2'-DEOXY-3'-THIACYTIDINE IN PATIENTS WITH AIDS OR ADVANCED AIDS-RELATED COMPLEX, AIDS, 9(4), 1995, pp. 351-357
K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE
Authors: GU ZX SALOMON H CHERRINGTON JM MULATO AS CHEN MS YARCHOAN R FOLI A SOGOCIO KM WAINBERG MA
Citation: Zx. Gu et al., K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1888-1891
ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AND ANTI-HEPATITIS-B VIRUS ACTIVITIES AND TOXICITIES OF THE ENANTIOMERS OF 2-DEOXY-3-OXA-4-THIOCYTIDINE AND THEIR 5-FLUORO ANALOGS IN-VITRO
Authors: MANSOUR TS JIN HL WANG W HOOKER EU ASHMAN C CAMMACK N SALOMON H BELMONTE AR WAINBERG MA
Citation: Ts. Mansour et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AND ANTI-HEPATITIS-B VIRUS ACTIVITIES AND TOXICITIES OF THE ENANTIOMERS OF 2-DEOXY-3-OXA-4-THIOCYTIDINE AND THEIR 5-FLUORO ANALOGS IN-VITRO, Journal of medicinal chemistry, 38(1), 1995, pp. 1-4
A 3-WEEK HEPATITIS-B VACCINATION SCHEDULE PROVIDES RAPID AND PERSISTENT PROTECTIVE IMMUNITY - A MULTICENTER, RANDOMIZED TRIAL COMPARING ACCELERATED AND CLASSIC VACCINATION SCHEDULES
Authors: MARCHOU B EXCLER JL BOURDERIOUX C SALAUN J PICOT N YVONNET B CERISIER JE SALOMON H AUVERGNAT JC
Citation: B. Marchou et al., A 3-WEEK HEPATITIS-B VACCINATION SCHEDULE PROVIDES RAPID AND PERSISTENT PROTECTIVE IMMUNITY - A MULTICENTER, RANDOMIZED TRIAL COMPARING ACCELERATED AND CLASSIC VACCINATION SCHEDULES, The Journal of infectious diseases, 172(1), 1995, pp. 258-260
DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/
Authors: MONTANER JSG SCHECHTER MT RACHLIS A GILL J BEAULIEU R TSOUKAS C RABOUD J CAMERON B SALOMON H DUNKLE L SMALDONE L WAINBERG MA FANNING M LALONDE R BERGERON M SCHLECH W SALIT I PHILLIPS P SPIRA B CONWAY B CASSOL S OSHAUGNESSY M THORNE A SINGER J AUCLAIR C
Citation: Jsg. Montaner et al., DIDANOSINE COMPARED WITH CONTINUED ZIDOVUDINE THERAPY FOR HIV-INFECTED PATIENTS WITH 200 TO 500 CD4 CELLS MM(3) - A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL/, Annals of internal medicine, 123(8), 1995, pp. 561-571
GENERATION OF MULTIPLE-DRUG RESISTANCE BY SEQUENTIAL IN-VITRO PASSAGEOF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: GAO Q GU Z SALOMON H NAGAI K PARNIAK MA WAINBERG MA
Citation: Q. Gao et al., GENERATION OF MULTIPLE-DRUG RESISTANCE BY SEQUENTIAL IN-VITRO PASSAGEOF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Archives of virology, 136(1-2), 1994, pp. 111-122
RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT INTERLEUKIN-2 IN CHRONIC UREMIC PATIENTS WHO ARE NONRESPONDERS TO HEPATITIS-B VACCINE
Authors: JUNGERS P DEVILLIER P SALOMON H CERISIER JE COUROUCE A
Citation: P. Jungers et al., RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT INTERLEUKIN-2 IN CHRONIC UREMIC PATIENTS WHO ARE NONRESPONDERS TO HEPATITIS-B VACCINE, Lancet, 344(8926), 1994, pp. 856-857
COMPARISON OF CORD-BLOOD AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS AS TARGETS FOR VIRAL ISOLATION AND DRUG-SENSITIVITY STUDIES INVOLVING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: SALOMON H BELMONTE A NGUYEN K GU ZX GELFAND M WAINBERG MA
Citation: H. Salomon et al., COMPARISON OF CORD-BLOOD AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS AS TARGETS FOR VIRAL ISOLATION AND DRUG-SENSITIVITY STUDIES INVOLVING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of clinical microbiology, 32(8), 1994, pp. 2000-2002
IDENTIFICATION OF A MUTATION AT CODON-65 IN THE IKKK MOTIF OF REVERSE-TRANSCRIPTASE THAT ENCODES HUMAN-IMMUNODEFICIENCY-VIRUS RESISTANCE TO2',3'-DIDEOXYCYTIDINE AND 2',3'-DIDEOXY-3'-THIACYTIDINE
Authors: GU ZX GAO Q FANG HS SALOMON H PARNIAK MA GOLDBERG E CAMERON J WAINBERG MA
Citation: Zx. Gu et al., IDENTIFICATION OF A MUTATION AT CODON-65 IN THE IKKK MOTIF OF REVERSE-TRANSCRIPTASE THAT ENCODES HUMAN-IMMUNODEFICIENCY-VIRUS RESISTANCE TO2',3'-DIDEOXYCYTIDINE AND 2',3'-DIDEOXY-3'-THIACYTIDINE, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 275-281
ACUTE LOWER RESPIRATORY-INFECTION IN ARGENTINEAN CHILDREN - A 40 MONTH CLINICAL AND EPIDEMIOLOGIC-STUDY
Authors: MURTAGH P CERQUEIRO C HALAC A AVILA M SALOMON H WEISSENBACHER M
Citation: P. Murtagh et al., ACUTE LOWER RESPIRATORY-INFECTION IN ARGENTINEAN CHILDREN - A 40 MONTH CLINICAL AND EPIDEMIOLOGIC-STUDY, Pediatric pulmonology, 16(1), 1993, pp. 1-8
Risultati: 1-25 | 26-26